Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference11%
- Check25 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The core page content now reflects the newer release identifier; other substantive content remains unchanged.SummaryDifference0.3%
- Check39 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; Back to Top element removed (minor UI change).SummaryDifference0.6%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.6%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference30%
- Check68 days agoChange DetectedThe web page has been updated to version 2.16.12, replacing the previous version 2.16.11.SummaryDifference0.3%
Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.